<p>Investigational Treatment Agents for Recurrent <em>Clostridioides difficile</em> Infection (rCDI)</p>-Reference-Cited by-同舟云学术

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)

Published:2020-10 Issue: Volume:Volume 12 Page:371-384
ISSN:1179-1454
Container-title:Journal of Experimental Pharmacology
language:en
Short-container-title:JEP

Author:

Kullar Ravina,Tran Mai-Chi N,Goldstein Ellie JC

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Molecular Medicine

Reference89 articles.

1. Centers for Disease Control and Prevention. Biggest threats and data; 2020. Atlanta, GA. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html. Accessed May 22, 2020.

2. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

3. Clostridium difficile infection and antibiotic-associated diarrhoea

4. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

5. Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides;World Journal of Microbiology and Biotechnology;2024-08-20

2. Identification of Micrococcin P2-Derivatives as Antibiotic Candidates against Two Gram-Positive Pathogens;Journal of Medicinal Chemistry;2023-10-05

3. Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance;European Journal of Medicinal Chemistry;2023-08

4. Bifunctional antibiotic hybrids: A review of clinical candidates;Frontiers in Pharmacology;2023-06-12

5. The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects;Biomedicines;2023-02-01